FDA Awards CTIP 5 Year Grant to Support Pediatric Medical Device Innovation

CHICAGO, ILLINOIS - DECEMBER 11, 2023 - The Consortium for Technology & Innovation in Pediatrics (CTIP) was awarded another five-year Pediatric Device Consortia (PDC) grant totaling $5.75M by the FDA’s Office of Orphan Products Development (OOPD) to continue our essential work of improving child health outcomes by advancing pediatric medical devices. CTIP, based at Lurie Children’s Hospital (LCH) and Children's Hospital Los Angeles (CHLA), is one of only five centers across the country awarded a PDC grant for the 2023-2028 cycle. 

For more information about the PDC program, please visit: https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/pediatric-device-consortia-grants-program 

Lurie Children’s Hospital Press Release: https://www.luriechildrens.org/en/news-stories/fda-awards-ctip-another-five-year-grant-to-support-pediatric-medical-device-innovation/ 

Watch a short video about CTIP’s impact: https://www.youtube.com/watch?v=nm4C3_mdmOE 

Established in 2011, CTIP has been funded by the FDA’s PDC grant program in 2013, 2018, and 2023. CTIP promotes the development and commercialization of pediatric medical devices by simultaneously engaging and coordinating clinicians, engineers, regulators, hospital administrators, industry, patients, and the business community to guide and support medical device development for children. CTIP has established a robust network of children’s hospitals, academic institutions, accelerators, incubators, and ecosystem partners to support the commercialization of pediatric medical devices. Over the past ten years, CTIP’s network has steadily grown from local to national membership, with 26 institutions across 8 states participating in the 2023-2028 cycle.

During the 2018-2023 grant cycle, CTIP supported 145 unique projects from 26 different states. CTIP invested nearly $2.4M in direct and indirect funding for our portfolio companies. These companies have raised over $600M over the past five years, including $38M worth of non-dilutive federal grants. There are 25 regulated medical devices on the market from CTIP portfolio members, including eleven 510(k) devices and two De Novos. 

CTIP has been a leader in fostering diversity, equity and inclusion in the field of pediatric medical devices. We are deeply committed to supporting individuals from diverse and historically underrepresented backgrounds in the fields of science, technology, engineering, medicine and business in all roles in the MedTech ecosystem, including patients, clinicians, researchers, founders, and investors. In order to keep ourselves accountable, CTIP has been tracking diversity metrics about our portfolio since 2018. To date, 75% of our Portfolio members have voluntarily self-reported their intersectional identities, showing that the senior leadership teams of our portfolio members are 55% Women, 44% Underrepresented in Medicine(URM)/People of Color,  6% LGBTQ+, and 5% Veterans. Our partnerships with organizations like MedTech Color, Women in VC, and Women of Community help us identify and invest in pediatric device innovators from URM backgrounds.

The current grant cycle includes exciting new initiatives for CTIP, including:

  • Growth and expansion of the Medical Device Clinical Trials Unit (MDCTU) - Emboldened by the MDCTU pilot success at CHLA, CTIP engaged with Lurie Children's to incorporate our services into the existing clinical research infrastructure and expand our offerings to support clinical research for pediatric medical device development.
  • Investor Advisory Board - CTIP will launch its inaugural Investor Advisory Board, comprised of individuals who allocate capital or influence capital allocation towards medical device projects, to help founders tackle the financial barriers that exacerbate the pediatric medtech innovation gap. The group, which represents individuals from venture capital firms, corporate venture funds, foundations, family offices, venture studios, accelerators, investment banks, private equity, and law, will contribute valuable insights and strategic guidance around capital raising to pave the way for pediatric Medtech founders’ success.
  • Patient Engagement and Advocacy Initiatives - CTIP is implementing multiple strategies to engage with and advocate for patients in pediatric medical device development. With the support of CTIP collaborators, we aim to incorporate the perspectives of children and their families to help identify unmet needs and bring medical devices to market that fit the needs and growth of pediatric patients.
  • CTIP’s Consortium Community - The Consortium Community serves as a collaborative network to enable our 26 CTIP partner organizations to benefit from education, information exchange, and best practice sharing, with an objective to advance pediatric MedTech innovation infrastructure.

To accomplish these critical initiatives, the CTIP team has grown; our multidisciplinary team includes:

Stay updated with the latest news from CTIP. Sign up for the CTIP newsletter: https://airtable.com/appBBuifQ4QjGPy3k/shrqIfQ2GoAFsRhlj 

For more updates from CTIP about pediatric MedTech follow us @ctipmedtech on Twitter, Facebook & Instagram, Consortium for Technology & Innovation in Pediatrics on LinkedIn and the web at www.ctipmedtech.org.

The Consortium for Technology & Innovation in Pediatrics (CTIP) is an FDA-funded pediatric MedTech accelerator centered at Lurie Children’s Hospital (LCH) and Children's Hospital Los Angeles (CHLA). Our goal is to facilitate the development, production, and distribution of pediatric medical devices by identifying companies working in the space and providing advice, networking, and direct and indirect financial support on the road to commercialization.

Questions? Please contact us at info@ctipmedtech.org.